You are in:Home/Publications/Increased Serum Visfatin Levels in Patients with Type2 Diabetic Patients

Prof. Hesham Ali Mohamed Abdel-Halim Issa :: Publications:

Title:
Increased Serum Visfatin Levels in Patients with Type2 Diabetic Patients
Authors: Osama S El-Shaer, Khaled M Belal, Hesham A Issa, Tawfik El-Adl
Year: 2012
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Background: Obesity is highly associated with insulin resistance and the increased risk of type 2 diabetes and cardiovascular diseases. Visfatin is a cytokine that is highly expressed in visceral fat. It's expression in visceral fat is increased in obese subjects. Visfatin exerts insulin-mimetic effects and was as effective as insulin in reducing hyperglycemia in insulin-deficient diabetic mice. Objective: To study serum visfatin level in patients with type2 diabetes mellitus and to clarify its possible relationship with insulin

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus